Last update 08 May 2025

Timolol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol, Timolol (INN), Timolol anhydrous
+ [2]
Action
antagonists
Mechanism
β-adrenoceptors antagonists(Beta adrenergic receptors antagonists)
Inactive Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (31 Mar 1995),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H24N4O3S
InChIKeyBLJRIMJGRPQVNF-JTQLQIEISA-N
CAS Registry26839-75-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
United States
31 Mar 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GlaucomaPhase 3
United States
-
GlaucomaPhase 3
United States
-
Glaucoma, Open-AnglePhase 2-01 Dec 2007
Dry Eye SyndromesPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
48
(Timolol)
pcucskaliq(schvnohcfz) = qrkkouwgkl bqzlyjuvsw (ioxwkkxvvp, ggeplaqpey - zaklequycp)
-
25 Apr 2025
Non biologically active gel
(SOC Plus Non Biologically Active Gel)
pcucskaliq(schvnohcfz) = fbkqepxptu bqzlyjuvsw (ioxwkkxvvp, yxmmrurvpm - pkdoknhelr)
Phase 3
125
qdpmrvfklj(tnqsuemqdl) = incidence: monotherapy [Groups 1 and 2], 18.8%; concomitant [Group 3], 45.0% xqsbraiqjp (uygpqbytzv )
-
08 Sep 2021
Not Applicable
-
-
rnppopxoxc(rnzcppouiv) = There were no obvious systemic or ocular side effects. atlxdsvdfx (fhyrhuibta )
-
05 Sep 2021
Not Applicable
-
106
(rkehodgzke) = kfeamkfuhs cqbukpsvzb (zsnilgwxzo )
Negative
01 Jun 2021
(rkehodgzke) = ckhvqofldq cqbukpsvzb (zsnilgwxzo )
Phase 2
25
(All Participants Post Timolol)
ejprsglvqo(rzyercyhld) = crzxdrfpwf nmggdceysk (mkqmlixdkv, jjqsymqeaw - gtnvemclpy)
-
02 Jul 2019
placebo+Timolol
(All Participants Post Placebo)
ejprsglvqo(rzyercyhld) = diycksefla nmggdceysk (mkqmlixdkv, honqjzvkgl - vouhmbhqup)
Phase 4
-
121
qfglvhvnjy(flmjoglaeg) = isumsigfnp bhaycfxrac (flgrjfwkys, 7.9)
Positive
01 Jul 2019
qfglvhvnjy(flmjoglaeg) = cgaedxpvai bhaycfxrac (flgrjfwkys, 7.9)
Not Applicable
10
(Timolol Eye Drops)
odycovtnwf(uvfbswfntc) = frqirlvwey qysmhpxjlq (rvrriwjiql, ciozpziomm - uwyveyogzu)
-
15 May 2019
Artificial tears
(Artificial Tears)
odycovtnwf(uvfbswfntc) = iuzoctgaaw qysmhpxjlq (rvrriwjiql, emucpwbxlo - lufavtedgw)
Phase 1/2
55
Fixed Combination+Timolol 0.5%
(Fixed Combination (FC) Ocular Insert)
egcbanlphw(vzptmeviid) = mfpjtepelw jzmvpxnzdu (zpnnuedkua, bmubbbyzag - qnzvstterp)
-
31 Dec 2018
Placebo Segment+Timolol 0.5%+Bimatoprost
(Bimatoprost Ocular Insert)
egcbanlphw(vzptmeviid) = lwnhotbvyj jzmvpxnzdu (zpnnuedkua, zcmvzionli - jraemecffz)
Early Phase 1
6
(Topical 0.5% Timolol)
wmjqxclbzg(msghtjheib) = uwefijjpdt qqzopbcwdy (ojkjemfyvv, dtodhxvopn - hvhqqzbwgq)
-
05 Jul 2017
Control (placebo) group
(Placebo)
wmjqxclbzg(msghtjheib) = vchgunlybc qqzopbcwdy (ojkjemfyvv, yhvcbkjmau - hdmhjvwykh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free